연구동향 분석
박사

The Role of TRIF and RIP2 and Inhibitory effect of Mycobacterium tuberculosis derived Heat shock protein 70 on Development of Allergic Airway Inflammation : 알러지성 기도 염증 발생에서 TRIF과 RIP2의 역할 및 결핵균 유래 열충격 단백질70의 억제효과

김태현 2015년

논문상세정보
인용/피인용
' The Role of TRIF and RIP2 and Inhibitory effect of Mycobacterium tuberculosis derived Heat shock protein 70 on Development of Allergic Airway Inflammation : 알러지성 기도 염증 발생에서 TRIF과 RIP2의 역할 및 결핵균 유래 열충격 단백질70의 억제효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • allergic airway inflammation
  • dendritic cells
  • heat shock protein 70
  • mycobacterium tuberculosis
  • nod-like receptors
  • pattern recognition receptors
  • toll-like receptors
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
191 0

0.0%

' The Role of TRIF and RIP2 and Inhibitory effect of Mycobacterium tuberculosis derived Heat shock protein 70 on Development of Allergic Airway Inflammation : 알러지성 기도 염증 발생에서 TRIF과 RIP2의 역할 및 결핵균 유래 열충격 단백질70의 억제효과' 의 참고문헌

  • Yazdanbakhsh, M., Kremsner, P.G., and van Ree, R. (2002). Allergy, parasites, and thehygiene hypothesis. Science 296, 490-494.
  • Yarovinsky, F., Zhang, D., Andersen, J.F., Bannenberg, G.L., Serhan, C.N., Hayden, M.S.,Hieny, S., Sutterwala, F.S., Flavell, R.A., Ghosh, S., et al. (2005). TLR11 activation ofdendritic cells by a protozoan profilin-like protein. Science 308, 1626-1629.
  • Yang, X., Wang, S., Fan, Y., and Zhu, L. (1999). Systemic mycobacterial infectioninhibits antigen-specific immunoglobulin E production, bronchial mucus production andeosinophilic inflammation induced by allergen. Immunology 98, 329-337.
  • Xirakia, C., Koltsida, O., Stavropoulos, A., Thanassopoulou, A., Aidinis, V., Sideras, P.,and Andreakos, E. (2010). Toll-like receptor 7-triggered immune response in the lungmediates acute and long-lasting suppression of experimental asthma. Am J Respir CritCare Med 181, 1207-1216.
  • Xia, Z.P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., and Chen, Z.J.(2009). Direct activation of protein kinases by unanchored polyubiquitin chains. Nature461, 114-119.
  • Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., andDonaldson, D.D. (1998). Interleukin-13: central mediator of allergic asthma. Science 282,2258-2261.
  • Wills-Karp, M. (2004). Interleukin-13 in asthma pathogenesis. Immunol Rev 202, 175-190.
  • Williams, T.J. (2004). The eosinophil enigma. J Clin Invest 113, 507-509.
  • Williams, J.W., Tjota, M.Y., and Sperling, A.I. (2012). The contribution of allergenspecificIgG to the development of th2-mediated airway inflammation. J Allergy (Cairo)2012, 236075.
  • Williams, C.M., and Galli, S.J. (2000). The diverse potential effector andimmunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 105,847-859.
  • Wenzel, S.E. (2006). Asthma: defining of the persistent adult phenotypes. Lancet 368,804-813.
  • Watanabe, T., Kitani, A., and Strober, W. (2005). NOD2 regulation of Toll-like receptorresponses and the pathogenesis of Crohn’s disease. Gut 54, 1515-1518.
  • Watanabe, T., Kitani, A., Murray, P.J., and Strober, W. (2004). NOD2 is a negativeregulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5, 800-808.
  • Wang, Y., Kelly, C.G., Singh, M., McGowan, E.G., Carrara, A.S., Bergmeier, L.A., andLehner, T. (2002). Stimulation of Th1-polarizing cytokines, C-C chemokines, maturationof dendritic cells, and adjuvant function by the peptide binding fragment of heat shockprotein 70. J Immunol 169, 2422-2429.
  • Wang, Y., Kelly, C.G., Karttunen, J.T., Whittall, T., Lehner, P.J., Duncan, L., MacAry, P.,Younson, J.S., Singh, M., Oehlmann, W., et al. (2001b). CD40 is a cellular receptormediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity15, 971-983.
  • Wang, J.E., Jorgensen, P.F., Ellingsen, E.A., Almiof, M., Thiemermann, C., Foster, S.J.,Aasen, A.O., and Solberg, R. (2001a). Peptidoglycan primes for LPS-induced release ofproinflammatory cytokines in whole human blood. Shock 16, 178-182.
  • Walker, R.I. (1994). New strategies for using mucosal vaccination to achieve moreeffective immunization. Vaccine 12, 387-400.
  • Walker, C., Bode, E., Boer, L., Hansel, T.T., Blaser, K., and Virchow, J.C., Jr. (1992).Allergic and nonallergic asthmatics have distinct patterns of T-cell activation andcytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis１６８146, 109-115.
  • Velasco, G., Campo, M., Manrique, O.J., Bellou, A., He, H., Arestides, R.S., Schaub, B.,Perkins, D.L., and Finn, P.W. (2005). Toll-like receptor 4 or 2 agonists decrease allergicinflammation. Am J Respir Cell Mol Biol 32, 218-224.
  • Vabulas, R.M., Ahmad-Nejad, P., Ghose, S., Kirschning, C.J., Issels, R.D., and Wagner, H.(2002). HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway.J Biol Chem 277, 15107-15112.
  • Uehara, A., Yang, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Shibata, K., Sugawara, S.,and Takada, H. (2005). Muramyldipeptide and diaminopimelic acid-containingdesmuramylpeptides in combination with chemically synthesized Toll-like receptoragonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol 7,53-61.
  • Traub, S., von Aulock, S., Hartung, T., and Hermann, C. (2006). MDP and other１６７muropeptides--direct and synergistic effects on the immune system. J Endotoxin Res 12,69-85.
  • Torres, D., Dieudonne, A., Ryffel, B., Vilain, E., Si-Tahar, M., Pichavant, M., Lassalle, P.,Trottein, F., and Gosset, P. (2010). Double-stranded RNA exacerbates pulmonary allergicreaction through TLR3: implication of airway epithelium and dendritic cells. J Immunol185, 451-459.
  • Torigoe, T., Tamura, Y., and Sato, N. (2009). Heat shock proteins and immunity:application of hyperthermia for immunomodulation. Int J Hyperthermia 25, 610-616.
  • To, T., Stanojevic, S., Moores, G., Gershon, A.S., Bateman, E.D., Cruz, A.A., and Boulet,L.P. (2012). Global asthma prevalence in adults: findings from the cross-sectional worldhealth survey. BMC Public Health 12, 204.
  • Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation. Cell140, 805-820.
  • Takatsu, K., Takaki, S., and Hitoshi, Y. (1994). Interleukin-5 and its receptor system:implications in the immune system and inflammation. Adv Immunol 57, 145-190.
  • Suzue, K., and Young, R.A. (1996). Adjuvant-free hsp70 fusion protein system elicitshumoral and cellular immune responses to HIV-1 p24. J Immunol 156, 873-879.
  • Stowell, N.C., Seideman, J., Raymond, H.A., Smalley, K.A., Lamb, R.J., Egenolf, D.D.,Bugelski, P.J., Murray, L.A., Marsters, P.A., Bunting, R.A., et al. (2009). Long-termactivation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice.Respir Res 10, 43.
  • Shifren, A., Witt, C., Christie, C., and Castro, M. (2012). Mechanisms of remodeling inasthmatic airways. J Allergy (Cairo) 2012, 316049.
  • Shalaby, K.H., Allard-Coutu, A., O'Sullivan, M.J., Nakada, E., Qureshi, S.T., Day, B.J.,and Martin, J.G. (2013). Inhaled birch pollen extract induces airway hyperresponsivenessvia oxidative stress but independently of pollen-intrinsic NADPH oxidase activity, or theTLR4-TRIF pathway. J Immunol 191, 922-933.
  • Shah, J.A., Darrah, P.A., Ambrozak, D.R., Turon, T.N., Mendez, S., Kirman, J., Wu, C.Y.,Glaichenhaus, N., and Seder, R.A. (2003). Dendritic cells are responsible for the capacityof CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunityagainst Leishmania major in mice. J Exp Med 198, 281-291.
  • Selvanantham, T., Escalante, N.K., Cruz Tleugabulova, M., Fieve, S., Girardin, S.E.,Philpott, D.J., and Mallevaey, T. (2013). Nod1 and Nod2 Enhance TLR-MediatedInvariant NKT Cell Activation during Bacterial Infection. The Journal of Immunology191, 5646-5654.
  • Schmitt, E., Gehrmann, M., Brunet, M., Multhoff, G., and Garrido, C. (2007).Intracellular and extracellular functions of heat shock proteins: repercussions in cancertherapy. J Leukoc Biol 81, 15-27.
  • Schlecht, R., Erbse, A.H., Bukau, B., and Mayer, M.P. (2011). Mechanics of Hsp70chaperones enables differential interaction with client proteins. Nat Struct Mol Biol 18,345-351.
  • Sampson, A.P. (2000). The role of eosinophils and neutrophils in inflammation. Clin ExpAllergy 30 Suppl 1, 22-27.
  • Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. (1995). Dendritic cells usemacropinocytosis and the mannose receptor to concentrate macromolecules in the majorhistocompatibility complex class II compartment: downregulation by cytokines andbacterial products. J Exp Med 182, 389-400.
  • Saibil, H. (2013). Chaperone machines for protein folding, unfolding and disaggregation.Nat Rev Cancer 13, 630-642.
  • Sahiner, U.M., Jusufagic, A.S., Curtin, J.A., Birben, E., Belgrave, D., Sackesen, C.,Simpson, A., Yavuz, T.S., Akdis, C.A., Custovic, A., et al. (2014). Polymorphisms ofendotoxin pathway and endotoxin exposure: in-vitro IgE synthesis and replication in a１６４birth cohort. Allergy.
  • Ryu, J.H., Yoo, J.Y., Kim, M.J., Hwang, S.G., Ahn, K.C., Ryu, J.C., Choi, M.K., Joo, J.H.,Kim, C.H., Lee, S.N., et al. (2013). Distinct TLR-mediated pathways regulate house dustmite-induced allergic disease in the upper and lower airways. J Allergy Clin Immunol 131,549-561.
  • Robinson, D.S. (2004). The role of the mast cell in asthma: induction of airwayhyperresponsiveness by interaction with smooth muscle? J Allergy Clin Immunol 114, 58-65.
  • Robinson, D.S. (2000). Th-2 cytokines in allergic disease. Br Med Bull 56, 956-968.
  • Rivera, E., Hu, S., and Concha, C. (2003). Ginseng and aluminium hydroxide actsynergistically as vaccine adjuvants. Vaccine 21, 1149-1157.
  • Ritossa, P. (1962). [Problems of prophylactic vaccinations of infants]. Riv Ist Sieroter Ital37, 79-108.
  • Rha, Y.H., Taube, C., Haczku, A., Joetham, A., Takeda, K., Duez, C., Siegel, M., Aydintug,M.K., Born, W.K., Dakhama, A., et al. (2002). Effect of microbial heat shock proteins on１６３airway inflammation and hyperresponsiveness. J Immunol 169, 5300-5307.
  • Reed, C.E., and Milton, D.K. (2001). Endotoxin-stimulated innate immunity: Acontributing factor for asthma. J Allergy Clin Immunol 108, 157-166.
  • Quaratino, S., Duddy, L.P., and Londei, M. (2000). Fully competent dendritic cells asinducers of T cell anergy in autoimmunity. Proc Natl Acad Sci U S A 97, 10911-10916.
  • Qazi, K.R., Oehlmann, W., Singh, M., Lopez, M.C., and Fernandez, C. (2007). Microbialheat shock protein 70 stimulatory properties have different TLR requirements. Vaccine 25,1096-1103.
  • Petrovsky, N., and Aguilar, J.C. (2004). Vaccine adjuvants: current state and future trends.Immunol Cell Biol 82, 488-496.
  • Peters-Golden, M. (2004). The alveolar macrophage: the forgotten cell in asthma. Am JRespir Cell Mol Biol 31, 3-7.
  • Patel, M., Xu, D., Kewin, P., Choo-Kang, B., McSharry, C., Thomson, N.C., and Liew,F.Y. (2005). TLR2 agonist ameliorates established allergic airway inflammation bypromoting Th1 response and not via regulatory T cells. J Immunol 174, 7558-7563.
  • Park, S.R., Kim, D.J., Han, S.H., Kang, M.J., Lee, J.Y., Jeong, Y.J., Lee, S.J., Kim, T.H.,Ahn, S.G., Yoon, J.H., et al. (2014). Diverse Toll-like receptors mediate cytokineproduction by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans inmacrophages. Infect Immun 82, 1914-1920.
  • Park, J.H., Kim, Y.G., and Nunez, G. (2009b). RICK promotes inflammation and lethalityafter gram-negative bacterial infection in mice stimulated with lipopolysaccharide.Infection and immunity 77, 1569-1578.
  • Park, B.S., Song, D.H., Kim, H.M., Choi, B.S., Lee, H., and Lee, J.O. (2009a). Thestructural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature458, 1191-1195.
  • Panjwani, N.N., Popova, L., and Srivastava, P.K. (2002). Heat shock proteins gp96 andhsp70 activate the release of nitric oxide by APCs. J Immunol 168, 2997-3003.
  • Pang, Q., Christianson, T.A., Keeble, W., Koretsky, T., and Bagby, G.C. (2002). The antiapoptoticfunction of Hsp70 in the interferon-inducible double-stranded RNA-dependentprotein kinase-mediated death signaling pathway requires the Fanconi anemia protein,FANCC. J Biol Chem 277, 49638-49643.
  • Nicholson, K.G., Kent, J., and Ireland, D.C. (1993). Respiratory viruses and１６１exacerbations of asthma in adults. BMJ 307, 982-986.
  • Nguyen, T.H., and Casale, T.B. (2011). Immune modulation for treatment of allergicdisease. Immunol Rev 242, 258-271.
  • Netea, M.G., Ferwerda, G., de Jong, D.J., Jansen, T., Jacobs, L., Kramer, M., Naber, T.H.,Drenth, J.P., Girardin, S.E., Kullberg, B.J., et al. (2005). Nucleotide-bindingoligomerization domain-2 modulates specific TLR pathways for the induction of cytokinerelease. J Immunol 174, 6518-6523.
  • Nembrini, C., Sichelstiel, A., Kisielow, J., Kurrer, M., Kopf, M., and Marsland, B.J.(2011). Bacterial-induced protection against allergic inflammation through amulticomponent immunoregulatory mechanism. Thorax 66, 755-763.
  • Nelson, H.S. (1995). Beta-adrenergic bronchodilators. N Engl J Med 333, 499-506.
  • National Heart, L., and Asthma, B.I.N.A.E.P.E.P.o.t.M.o. (2007). Expert Panel Report 3:Guidelines for the Diagnosis and Management of Asthma: Full Report (US Department ofHealth and Human Services, National Institutes of Health, National Heart, Lung, andBlood Institute).
  • Nakashima, K., Hirota, T., Suzuki, Y., Akahoshi, M., Shimizu, M., Jodo, A., Doi, S.,Fujita, K., Ebisawa, M., Yoshihara, S., et al. (2006). Association of the RIP2 gene with１６０childhood atopic asthma. Allergol Int 55, 77-83.
  • Murphy, M.E. (2013). The HSP70 family and cancer. Carcinogenesis 34, 1181-1188.
  • Moser, M., and Murphy, K.M. (2000). Dendritic cell regulation of TH1-TH2 development.Nat Immunol 1, 199-205.
  • Moon, P.D., Choi, I.H., and Kim, H.M. (2011). Naringenin suppresses the production ofthymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascadein mast cells. Eur J Pharmacol 671, 128-132.
  • McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M., and Kiyono,H. (1992). The mucosal immune system: from fundamental concepts to vaccinedevelopment. Vaccine 10, 75-88.
  • McCluskie, M.J., Weeratna, R.D., Evans, D.M., Makinen, S., Drane, D., and Davis, H.L.(2013). CpG ODN and ISCOMATRIX adjuvant: a synergistic adjuvant combinationinducing strong T-Cell IFN-gamma responses. Biomed Res Int 2013, 636847.
  • Matsumoto, K., and Inoue, H. (2014). Viral infections in asthma and COPD. RespirInvestig 52, 92-100.
  • Masoli, M., Fabian, D., Holt, S., and Beasley, R. (2004). The global burden of asthma:executive summary of the GINA Dissemination Committee report. Allergy 59, 469-478.
  • Mancuso, G., Gambuzza, M., Midiri, A., Biondo, C., Papasergi, S., Akira, S., Teti, G., andBeninati, C. (2009). Bacterial recognition by TLR7 in the lysosomes of conventionaldendritic cells. Nat Immunol 10, 587-594.
  • Makela, M.J., Kanehiro, A., Dakhama, A., Borish, L., Joetham, A., Tripp, R., Anderson,L., and Gelfand, E.W. (2002). The failure of interleukin-10-deficient mice to developairway hyperresponsiveness is overcome by respiratory syncytial virus infection inallergen-sensitized/challenged mice. Am J Respir Crit Care Med 165, 824-831.
  • Magalhaes, J.G., Lee, J., Geddes, K., Rubino, S., Philpott, D.J., and Girardin, S.E. (2011).Essential role of Rip2 in the modulation of innate and adaptive immunity triggered byNod1 and Nod2 ligands. Eur J Immunol 41, 1445-1455.
  • Lutz, M.B., Kukutsch, N., Ogilvie, A.L., Rossner, S., Koch, F., Romani, N., and Schuler,G. (1999). An advanced culture method for generating large quantities of highly puredendritic cells from mouse bone marrow. J Immunol Methods 223, 77-92.
  • Liu, Y.J. (2001). Dendritic cell subsets and lineages, and their functions in innate and１５８adaptive immunity. Cell 106, 259-262.
  • Leff, A.R. (2001). Regulation of leukotrienes in the management of asthma: biology andclinical therapy. Annu Rev Med 52, 1-14.
  • Leclerc, C., Audibert, F., and Chedid, L. (1978). Influence of a synthetic adjuvant (MDP)on qualitative and quantitative changes of serum globulins. Immunology 35, 963-970.
  • Leckie, M.J., ten Brinke, A., Khan, J., Diamant, Z., O'Connor, B.J., Walls, C.M., Mathur,A.K., Cowley, H.C., Chung, K.F., Djukanovic, R., et al. (2000). Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and thelate asthmatic response. Lancet 356, 2144-2148.
  • Larche, M., Robinson, D.S., and Kay, A.B. (2003). The role of T lymphocytes in thepathogenesis of asthma. J Allergy Clin Immunol 111, 450-463; quiz 464.
  • Lanneau, D., Brunet, M., Frisan, E., Solary, E., Fontenay, M., and Garrido, C. (2008).Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 12, 743-761.
  • Langenkamp, A., Messi, M., Lanzavecchia, A., and Sallusto, F. (2000). Kinetics of１５７dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. NatImmunol 1, 311-316.
  • Kumar, H., Kawai, T., and Akira, S. (2009). Pathogen recognition in the innate immuneresponse. Biochem J 420, 1-16.
  • Kobayashi, K., Inohara, N., Hernandez, L.D., Galan, J.E., Nunez, G., Janeway, C.A.,Medzhitov, R., and Flavell, R.A. (2002). RICK/Rip2/CARDIAK mediates signalling forreceptors of the innate and adaptive immune systems. Nature 416, 194-199.
  • Kitagaki, K., Businga, T.R., and Kline, J.N. (2006). Oral administration of CpG-ODNssuppresses antigen-induced asthma in mice. Clin Exp Immunol 143, 249-259.
  • Kim, Y.K., Oh, S.Y., Jeon, S.G., Park, H.W., Lee, S.Y., Chun, E.Y., Bang, B., Lee, H.S.,Oh, M.H., Kim, Y.S., et al. (2007). Airway exposure levels of lipopolysaccharidedetermine type 1 versus type 2 experimental asthma. J Immunol 178, 5375-5382.
  • Kim, Y.G., Park, J.H., Shaw, M.H., Franchi, L., Inohara, N., and Nunez, G. (2008). Thecytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defenseafter exposure to Toll-like receptor ligands. Immunity 28, 246-257.
  • Kim, Y.G., Park, J.H., Reimer, T., Baker, D.P., Kawai, T., Kumar, H., Akira, S., Wobus, C.,and Nunez, G. (2011). Viral infection augments Nod1/2 signaling to potentiate lethalityassociated with secondary bacterial infections. Cell Host Microbe 9, 496-507.
  • Kawai, T., and Akira, S. (2006). TLR signaling. Cell Death & Differentiation 13, 816-825.
  • Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., Saitoh, T.,Kawai, T., Takeuchi, O., and Akira, S. (2008). Sequential control of Toll-like receptordependentresponses by IRAK1 and IRAK2. Nat Immunol 9, 684-691.
  • Kapsenberg, M.L. (2003). Dendritic-cell control of pathogen-driven T-cell polarization.Nat Rev Immunol 3, 984-993.
  • Kamon, H., Kawabe, T., Kitamura, H., Lee, J., Kamimura, D., Kaisho, T., Akira, S.,Iwamatsu, A., Koga, H., Murakami, M., et al. (2006). TRIF-GEFH1-RhoB pathway isinvolved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation.EMBO J 25, 4108-4119.
  • Kaisho, T., Hoshino, K., Iwabe, T., Takeuchi, O., Yasui, T., and Akira, S. (2002).Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 celldifferentiation. Int Immunol 14, 695-700.
  • Kabesch, M., Peters, W., Carr, D., Leupold, W., Weiland, S.K., and von Mutius, E. (2003).Association between polymorphisms in caspase recruitment domain containing protein 15and allergy in two German populations. J Allergy Clin Immunol 111, 813-817.
  • Joshi, P., Shaw, A., Kakakios, A., and Isaacs, D. (2003). Interferon-gamma levels innasopharyngeal secretions of infants with respiratory syncytial virus and other respiratoryviral infections. Clin Exp Immunol 131, 143-147.
  • Jin, M.S., Kim, S.E., Heo, J.Y., Lee, M.E., Kim, H.M., Paik, S.G., Lee, H., and Lee, J.O.(2007). Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a triacylatedlipopeptide. Cell 130, 1071-1082.
  • Jarjour, N.N., and Kelly, E.A. (2002). Pathogenesis of asthma. Med Clin North Am 86,925-936.
  • Inohara, N., Koseki, T., Lin, J., del Peso, L., Lucas, P.C., Chen, F.F., Ogura, Y., and Nunez,G. (2000). An induced proximity model for NF-kappa B activation in the Nod1/RICK andRIP signaling pathways. J Biol Chem 275, 27823-27831.
  • Inohara, Chamaillard, McDonald, C., and Nunez, G. (2005). NOD-LRR proteins: role inhost-microbial interactions and inflammatory disease. Annu Rev Biochem 74, 355-383.
  • Hysi, P., Kabesch, M., Moffatt, M.F., Schedel, M., Carr, D., Zhang, Y., Boardman, B., von１５４Mutius, E., Weiland, S.K., Leupold, W., et al. (2005). NOD1 variation, immunoglobulinE and asthma. Hum Mol Genet 14, 935-941.
  • Hur, G.Y., Lee, S.Y., Lee, S.H., Kim, S.J., Lee, K.J., Jung, J.Y., Lee, E.J., Kang, E.H.,Jung, K.H., Kim, J.H., et al. (2007). Potential use of an anticancer drug gefinitib, anEGFR inhibitor, on allergic airway inflammation. Exp Mol Med 39, 367-375.
  • Huang, Q., Richmond, J.F., Suzue, K., Eisen, H.N., and Young, R.A. (2000). In vivocytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteinsmaps to a discrete domain and is CD4(+) T cell independent. J Exp Med 191, 403-408.
  • Hsia, B.J., Whitehead, G.S., Thomas, S.Y., Nakano, K., Gowdy, K.M., Aloor, J.J., Nakano,H., and Cook, D.N. (2014). Trif-dependent induction of Th17 immunity by lung dendriticcells. Mucosal Immunol.
  • Horak, F., Zieglmayer, P., Zieglmayer, R., Lemell, P., Newkirk, M., Manjarrez, K.,Randall, T., and Hershberg, R. (2011). Intranasal Toll-like receptor 8 agonist (VTX-1463)significantly improves symptoms of allergic rhinitis in a randomized, placebo-controlledtrial. Journal of Allergy and Clinical Immunology 127, AB199.
  • Hollingsworth, J.W., 2nd, Cook, D.N., Brass, D.M., Walker, J.K., Morgan, D.L., Foster,W.M., and Schwartz, D.A. (2004). The role of Toll-like receptor 4 in environmentalairway injury in mice. Am J Respir Crit Care Med 170, 126-132.
  • Hoebe, K., Janssen, E.M., Kim, S.O., Alexopoulou, L., Flavell, R.A., Han, J., and Beutler,B. (2003). Upregulation of costimulatory molecules induced by lipopolysaccharide anddouble-stranded RNA occurs by Trif-dependent and Trif-independent pathways. NatImmunol 4, 1223-1229.
  • Hiemstra, I.H., Bouma, G., Geerts, D., Kraal, G., and Haan, J.M.M.d. (2012). Nod2improves barrier function of intestinal epithelial cells via enhancement of TLR responses.Molecular Immunology 52, 264-272.
  • Hasegawa, M., Fujimoto, Y., Lucas, P.C., Nakano, H., Fukase, K., Nunez, G., and Inohara,N. (2008). A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaBactivation. EMBO J 27, 373-383.
  • Hammad, H., Chieppa, M., Perros, F., Willart, M.A., Germain, R.N., and Lambrecht, B.N.(2009). House dust mite allergen induces asthma via Toll-like receptor 4 triggering ofairway structural cells. Nat Med 15, 410-416.
  • Hacker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L.C., Wang, G.G., Kamps,M.P., Raz, E., Wagner, H., Hacker, G., et al. (2006). Specificity in Toll-like receptorsignalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207.
  • Haapakoski, R., Karisola, P., Fyhrquist, N., Savinko, T., Lehtimaki, S., Wolff, H.,Lauerma, A., and Alenius, H. (2013). Toll-like receptor activation during cutaneousallergen sensitization blocks development of asthma through IFN-gamma-dependent１５２mechanisms. J Invest Dermatol 133, 964-972.
  • Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott,D.J., and Sansonetti, P.J. (2003). Nod2 is a general sensor of peptidoglycan throughmuramyl dipeptide (MDP) detection. J Biol Chem 278, 8869-8872.
  • Gimmi, C.D., Freeman, G.J., Gribben, J.G., Gray, G., and Nadler, L.M. (1993). Human Tcellclonal anergy is induced by antigen presentation in the absence of B7 costimulation.Proc Natl Acad Sci U S A 90, 6586-6590.
  • Gerhold, K., Blumchen, K., Bock, A., Seib, C., Stock, P., Kallinich, T., Lohning, M.,Wahn, U., and Hamelmann, E. (2002). Endotoxins prevent murine IgE production, T(H)2immune responses, and development of airway eosinophilia but not airwayhyperreactivity. J Allergy Clin Immunol 110, 110-116.
  • Gelfand, E.W., and Dakhama, A. (2006). CD8+ T lymphocytes and leukotriene B4: novelinteractions in the persistence and progression of asthma. J Allergy Clin Immunol 117,577-582.
  • Galli, S.J., Kalesnikoff, J., Grimbaldeston, M.A., Piliponsky, A.M., Williams, C.M., andTsai, M. (2005). Mast cells as "tunable" effector and immunoregulatory cells: recent１５１advances. Annu Rev Immunol 23, 749-786.
  • Fujii, S., Shimizu, K., Smith, C., Bonifaz, L., and Steinman, R.M. (2003). Activation ofnatural killer T cells by alpha-galactosylceramide rapidly induces the full maturation ofdendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cellimmunity to a coadministered protein. J Exp Med 198, 267-279.
  • Fritz, J.H., Girardin, S.E., Fitting, C., Werts, C., Mengin-Lecreulx, D., Caroff, M.,Cavaillon, J.M., Philpott, D.J., and Adib-Conquy, M. (2005). Synergistic stimulation ofhuman monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol 35, 2459-2470.
  • Franken, K.L., Hiemstra, H.S., van Meijgaarden, K.E., Subronto, Y., den Hartigh, J.,Ottenhoff, T.H., and Drijfhout, J.W. (2000). Purification of his-tagged proteins byimmobilized chelate affinity chromatography: the benefits from the use of organic solvent.Protein Expr Purif 18, 95-99.
  • Fanta, C.H. (2009). Asthma. N Engl J Med 360, 1002-1014.
  • Fahy, J.V., Kim, K.W., Liu, J., and Boushey, H.A. (1995). Prominent neutrophilic１５０inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol95, 843-852.
  • Erb, K.J., Holloway, J.W., Sobeck, A., Moll, H., and Le Gros, G. (1998). Infection ofmice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergeninducedairway eosinophilia. J Exp Med 187, 561-569.
  • Elson, C.O. (1992). Cholera toxin as a mucosal adjuvant: effects of H-2 majorhistocompatibility complex and lps genes. Infect Immun 60, 2874-2879.
  • Ellouz, F., Adam, A., Ciorbaru, R., and Lederer, E. (1974). Minimal structuralrequirements for adjuvant activity of bacterial peptidoglycan derivatives. BiochemBiophys Res Commun 59, 1317-1325.
  • Eisenbarth, S.C., Piggott, D.A., Huleatt, J.W., Visintin, I., Herrick, C.A., and Bottomly, K.(2002). Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2responses to inhaled antigen. J Exp Med 196, 1645-1651.
  • Eder, W., Klimecki, W., Yu, L., von Mutius, E., Riedler, J., Braun-Fahrlander, C., Nowak,D., and Martinez, F.D. (2004). Toll-like receptor 2 as a major gene for asthma in childrenof European farmers. J Allergy Clin Immunol 113, 482-488.
  • Eder, W., Klimecki, W., Yu, L., von Mutius, E., Riedler, J., Braun-Fahrlander, C., Nowak,D., Holst, O., and Martinez, F.D. (2006). Association between exposure to farming,１４９allergies and genetic variation in CARD4/NOD1. Allergy 61, 1117-1124.
  • Duechs, M.J., Hahn, C., Benediktus, E., Werner-Klein, M., Braun, A., Hoymann, H.G.,Gantner, F., and Erb, K.J. (2011). TLR agonist mediated suppression of allergic responsesis associated with increased innate inflammation in the airways. Pulm Pharmacol Ther 24,203-214.
  • Drazen, J.M., Israel, E., and O'Byrne, P.M. (1999). Treatment of asthma with drugsmodifying the leukotriene pathway. N Engl J Med 340, 197-206.
  • Diebold, S.S. (2008). Determination of T-cell fate by dendritic cells. Immunol Cell Biol86, 389-397.
  • Delayre-Orthez, C., de Blay, F., Frossard, N., and Pons, F. (2004). Dose-dependent effectsof endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy 34,1789-1795.
  • Delayre-Orthez, C., Becker, J., de Blay, F., Frossard, N., and Pons, F. (2005). Exposure toendotoxins during sensitization prevents further endotoxin-induced exacerbation ofairway inflammation in a mouse model of allergic asthma. Int Arch Allergy Immunol 138,298-304.
  • De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P.,Urbain, J., Leo, O., and Moser, M. (1996). Regulation of dendritic cell numbers andmaturation by lipopolysaccharide in vivo. J Exp Med 184, 1413-1424.
  • De Becker, G., Moulin, V., Pajak, B., Bruck, C., Francotte, M., Thiriart, C., Urbain, J.,and Moser, M. (2000). The adjuvant monophosphoryl lipid A increases the function ofantigen-presenting cells. Int Immunol 12, 807-815.
  • Craig, E., Kang, P.J., and Boorstein, W. (1990). A review of the role of 70 kDa heat shockproteins in protein translocation across membranes. Antonie Van Leeuwenhoek 58, 137-146.
  • Cook, D.N., Pisetsky, D.S., and Schwartz, D.A. (2004). Toll-like receptors in thepathogenesis of human disease. Nat Immunol 5, 975-979.
  • Conrad, M.L., Ferstl, R., Teich, R., Brand, S., Blumer, N., Yildirim, A.O., Patrascan, C.C.,Hanuszkiewicz, A., Akira, S., Wagner, H., et al. (2009). Maternal TLR signaling isrequired for prenatal asthma protection by the nonpathogenic microbe Acinetobacterlwoffii F78. J Exp Med 206, 2869-2877.
  • Cohn, L., Elias, J.A., and Chupp, G.L. (2004). Asthma: mechanisms of disease１４７persistence and progression. Annu Rev Immunol 22, 789-815.
  • Coffman, R.L., Lebman, D.A., and Rothman, P. (1993). Mechanism and regulation ofimmunoglobulin isotype switching. Adv Immunol 54, 229-270.
  • Coban, C., Ishii, K.J., Kawai, T., Hemmi, H., Sato, S., Uematsu, S., Yamamoto, M.,Takeuchi, O., Itagaki, S., Kumar, N., et al. (2005). Toll-like receptor 9 mediates innateimmune activation by the malaria pigment hemozoin. J Exp Med 201, 19-25.
  • Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y., and Weiser, J.N. (2010).Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innateimmunity. Nat Med 16, 228-231.
  • Chung, F. (2001). Anti-inflammatory cytokines in asthma and allergy: interleukin-10,interleukin-12, interferon-gamma. Mediators Inflamm 10, 51-59.
  • Chu, H.W., and Martin, R.J. (2001). Are eosinophils still important in asthma? Clin ExpAllergy 31, 525-528.
  • Choe, J., Kelker, M.S., and Wilson, I.A. (2005). Crystal structure of human toll-likereceptor 3 (TLR3) ectodomain. Science 309, 581-585.
  • Chen, G., Shaw, M.H., Kim, Y.G., and Nunez, G. (2009). NOD-like receptors: role in１４６innate immunity and inflammatory disease. Annu Rev Pathol 4, 365-398.
  • Chang, T.W. (2000). The pharmacological basis of anti-IgE therapy. Nat Biotechnol 18,157-162.
  • Cegielska, A., and Georgopoulos, C. (1989). Functional domains of the Escherichia colidnaK heat shock protein as revealed by mutational analysis. J Biol Chem 264, 21122-21130.
  • Casale, T.B., Kessler, J., and Romero, F.A. (2006). Safety of the intranasal toll-likereceptor 4 agonist CRX-675 in allergic rhinitis. Ann Allergy Asthma Immunol 97, 454-456.
  • Busse, W.W., and Lemanske, R.F., Jr. (2001). Asthma. N Engl J Med 344, 350-362.
  • Busse, W.W., Brazinsky, S., Jacobson, K., Stricker, W., Schmitt, K., Vanden Burgt, J.,Donnell, D., Hannon, S., and Colice, G.L. (1999). Efficacy response of inhaledbeclomethasone dipropionate in asthma is proportional to dose and is improved byformulation with a new propellant. J Allergy Clin Immunol 104, 1215-1222.
  • Busse, W.W. (1996). The role of leukotrienes in asthma and allergic rhinitis. Clin ExpAllergy 26, 868-879.
  • Burrows, B., Martinez, F.D., Halonen, M., Barbee, R.A., and Cline, M.G. (1989).Association of asthma with serum IgE levels and skin-test reactivity to allergens. N EnglJ Med 320, 271-277.
  • Bulut, Y., Michelsen, K.S., Hayrapetian, L., Naiki, Y., Spallek, R., Singh, M., and Arditi,M. (2005). Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptorpathways to activate pro-inflammatory signals. J Biol Chem 280, 20961-20967.
  • Brenu, E.W., Staines, D.R., Tajouri, L., Huth, T., Ashton, K.J., and Marshall-Gradisnik,S.M. (2013). Heat shock proteins and regulatory T cells. Autoimmune Dis 2013, 813256.
  • Boyce, J.A. (2003). Mast cells: beyond IgE. J Allergy Clin Immunol 111, 24-32; quiz 33.
  • Bortolatto, J., Borducchi, E., Rodriguez, D., Keller, A.C., Faquim-Mauro, E., Bortoluci,K.R., Mucida, D., Gomes, E., Christ, A., Schnyder-Candrian, S., et al. (2008). Toll-likereceptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbuminspecificallergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis. Clin Exp Allergy 38, 1668-1679.
  • Bluestone, J.A. (1995). New perspectives of CD28-B7-mediated T cell costimulation.Immunity 2, 555-559.
  • Binder, R.J., Vatner, R., and Srivastava, P. (2004). The heat-shock protein receptors: someanswers and more questions. Tissue Antigens 64, 442-451.
  • Basu, S., and Fenton, M.J. (2004). Toll-like receptors: function and roles in lung disease.Am J Physiol Lung Cell Mol Physiol 286, L887-892.
  • Barbalat, R., Lau, L., Locksley, R.M., and Barton, G.M. (2009). Toll-like receptor 2 oninflammatory monocytes induces type I interferon in response to viral but not bacterialligands. Nat Immunol 10, 1200-1207.
  • Atmar, R.L., Guy, E., Guntupalli, K.K., Zimmerman, J.L., Bandi, V.D., Baxter, B.D., andGreenberg, S.B. (1998). Respiratory tract viral infections in inner-city asthmatic adults.Arch Intern Med 158, 2453-2459.
  • Asea, A., Rehli, M., Kabingu, E., Boch, J.A., Bare, O., Auron, P.E., Stevenson, M.A., andCalderwood, S.K. (2002). Novel signal transduction pathway utilized by extracellularHSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277, 15028-15034.
  • Asea, A., Kraeft, S.K., Kurt-Jones, E.A., Stevenson, M.A., Chen, L.B., Finberg, R.W.,Koo, G.C., and Calderwood, S.K. (2000). HSP70 stimulates cytokine production througha CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. NatMed 6, 435-442.
  • Arnold-Schild, D., Hanau, D., Spehner, D., Schmid, C., Rammensee, H.G., de la Salle, H.,and Schild, H. (1999). Cutting edge: receptor-mediated endocytosis of heat shockproteins by professional antigen-presenting cells. J Immunol 162, 3757-3760.
  • Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innateimmunity. Cell 124, 783-801.
  • Akbari, O., Faul, J.L., Hoyte, E.G., Berry, G.J., Wahlstrom, J., Kronenberg, M., DeKruyff,R.H., and Umetsu, D.T. (2006). CD4+ invariant T-cell-receptor+ natural killer T cells inbronchial asthma. N Engl J Med 354, 1117-1129.
  • Agrawal, D.K., and Shao, Z. (2010). Pathogenesis of allergic airway inflammation. CurrAllergy Asthma Rep 10, 39-48.
  • Abston, E.D., Coronado, M.J., Bucek, A., Bedja, D., Shin, J., Kim, J.B., Kim, E.,Gabrielson, K.L., Georgakopoulos, D., Mitzner, W., et al. (2012). Th2 regulation of viralmyocarditis in mice: different roles for TLR3 versus TRIF in progression to chronicdisease. Clin Dev Immunol 2012, 129486.
  • Abbas, A.K., Murphy, K.M., and Sher, A. (1996). Functional diversity of helper Tlymphocytes. Nature 383, 787-793.